Cargando…

NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8(+) T Cells

CD28-driven “signal 2” is critical for naïve CD8(+) T cell responses to dendritic cell (DC)-presented weak antigens, including non-mutated tumor-associated antigens (TAAs). However, it is unclear how DC-primed cytotoxic T lymphocytes (CTLs) respond to the same TAAs presented by cancer cells which la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Bowen, Obermajer, Nataša, Tsuji, Takemasa, Matsuzaki, Junko, Bonura, Cindy, Withers, Henry, Long, Mark, Chavel, Colin, Olejniczak, Scott H., Minderman, Hans, Edwards, Robert P., Storkus, Walter J., Romero, Pedro, Kalinski, Pawel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602189/ https://www.ncbi.nlm.nih.gov/pubmed/37886562 http://dx.doi.org/10.21203/rs.3.rs-3399211/v1

Ejemplares similares

Cognate Antigen Stimulation Generates Potent CD8(+) Inflammatory Effector T Cells
por: Sung, Hsueh-Cheng, et al.
Publicado: (2013)

A rare population of tumor antigen-specific CD4(+)CD8(+) double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells
por: Matsuzaki, Junko, et al.
Publicado: (2019)

Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells
por: Obermajer, Nataŝa, et al.
Publicado: (2012)

Generation of myeloid-derived suppressor cells using prostaglandin E(2)
por: Obermajer, Nataša, et al.
Publicado: (2012)

CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival
por: Utley, Adam, et al.
Publicado: (2020)

Expression of TAAs in glioblastoma and expansion of anti-TAA -reactive T cells
por: Dodoo, Ernest, et al.
Publicado: (2014)

Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma
por: Tauber, Catrin, et al.
Publicado: (2019)

Restoration of CD28 Expression in CD28(−) CD8(+) Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production
por: Topp, Max S., et al.
Publicado: (2003)

Effector CD4 T cell transition to memory requires late cognate interactions that induce autocrine IL-2
por: McKinstry, K. Kai, et al.
Publicado: (2014)

Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4(+) but Not CD8(+) T Cell Responses against p53 in Cancer Patients and Healthy Donors
por: Tsuji, Takemasa, et al.
Publicado: (2011)

Activation of the COX2-PGE(2 )axis by immune effector cells results in the self-limiting nature of type-1 immunity in cancer tissues
por: Wong, Jeffrey L, et al.
Publicado: (2014)

CD56(neg)CD16(+) NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
por: Milush, Jeffrey M, et al.
Publicado: (2013)

Complementary Dendritic Cell–activating Function of CD8(+) and CD4(+) T Cells: Helper Role of CD8(+) T Cells in the Development of T Helper Type 1 Responses
por: Mailliard, Robbie B., et al.
Publicado: (2002)

CD28nullCD4(+ )T cells: an effector memory T cell population in patients with rheumatoid arthritis
por: Fasth, AER, et al.
Publicado: (2004)

Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants
por: Ortega, Sterling B., et al.
Publicado: (2015)

61892 Systemic TLR3-targeting Combinatorial Chemokine Modulation Sensitizes Murine Tumors to PD-1 Blockade
por: Kokolus, Kathleen M., et al.
Publicado: (2021)

CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
por: Vitallé, Joana, et al.
Publicado: (2019)

CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool
por: Hendriks, Jenny, et al.
Publicado: (2003)

IL-18–induced CD83(+)CCR7(+) NK helper cells
por: Mailliard, Robbie B., et al.
Publicado: (2005)

Development and stability of Th17 cells in ovarian cancer requires nitric oxide and endogenous NOS2 activity in cancer-associated CD4+ T cells
por: Obermajer, Natasa, et al.
Publicado: (2013)

CD28(−) and CD28(low)CD8(+) Regulatory T Cells: Of Mice and Men
por: Vuddamalay, Yirajen, et al.
Publicado: (2017)

TaaI/Cdx-2 AA Variant of VDR Defines the Response to Phototherapy amongst Patients with Psoriasis
por: Lesiak, Aleksandra, et al.
Publicado: (2021)

Anomalous electronic structure and magnetoresistance in TaAs(2)
por: Luo, Yongkang, et al.
Publicado: (2016)

Use of Pro in Evaluating TAA and its Indications
por: Suri, Yash
Publicado: (2022)

Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy
por: Matsuzaki, Junko, et al.
Publicado: (2015)

Effective effector generation of CD8(+) T cells and NK cells: A need for T-bet and ZEB-too
por: Hamilton, Sara E., et al.
Publicado: (2015)

Legionella Metaeffector Exploits Host Proteasome to Temporally Regulate Cognate Effector
por: Kubori, Tomoko, et al.
Publicado: (2010)

Induction of a CD8(+) Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4(+) T Cell Help
por: Bennett, Sally R.M., et al.
Publicado: (1997)

Requirement of Cognate CD4(+) T-Cell Recognition for the Regulation of Allospecific CTL by Human CD4(+)CD127(−)CD25(+)FOXP3(+) Cells Generated in MLR
por: Yu, Yuming, et al.
Publicado: (2011)

Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
por: Matsuzaki, Junko, et al.
Publicado: (2015)

Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer
por: Matsuzaki, Junko, et al.
Publicado: (2022)

Induction of Th2 cell differentiation by cognate interaction of CD4 memory T cells
por: Skapenko, A, et al.
Publicado: (2002)

Cognate antigen engagement on parenchymal cells stimulates CD8(+) T cell proliferation in situ
por: Sutherland, Robyn M., et al.
Publicado: (2017)

CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs
por: Aly, Mostafa G., et al.
Publicado: (2021)

Tcf-1 protects anti-tumor TCR-engineered CD8(+) T-cells from GzmB mediated self-destruction
por: Zangari, Brendan, et al.
Publicado: (2022)

CD28/CD154 Blockade Prevents Autoimmune Diabetes by Inducing Nondeletional Tolerance After Effector T-Cell Inhibition and Regulatory T-Cell Expansion
por: Rigby, Mark R., et al.
Publicado: (2008)

Differential regulation of motility and immune synapses by CD28/ CTLA-4 costimulation in effector and regulatory T cells
por: Dilek, Nahzli, et al.
Publicado: (2012)

The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
por: Muller, Yannick D., et al.
Publicado: (2021)

The Tetraspanin CD53 Modulates Responses from Activating NK Cell Receptors, Promoting LFA-1 Activation and Dampening NK Cell Effector Functions
por: Todros-Dawda, Izabela, et al.
Publicado: (2014)

Computational Prediction and Molecular Characterization of an Oomycete Effector and the Cognate Arabidopsis Resistance Gene
por: Goritschnig, Sandra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_354qggp493dfi781m6cmapj93h